Also from this source

You just read:

Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency

News provided by

Ascendis Pharma A/S

Jul 30, 2015, 07:00 ET